|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02676 NOVOSENSE
Nominal 
() | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 95,054 | (139,409) | (228,831) |
| Net Cash from / (used in) Investing Activities | -- | (1,099,795) | 296,008 | (3,971,619) |
| Net Cash from / (used in) Financing Activities | -- | 266,812 | 332,157 | 5,389,880 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (737,929) | 488,756 | 1,189,430 |
| Cash & Cash Equivalents at beginning of period | -- | 1,751,191 | 1,264,617 | 77,738 |
| Effect of Foreign Exchange Rate Changes | -- | (1,047) | (2,182) | (2,551) |
| Others | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,012,215 | 1,751,191 | 1,264,617 |
| Remarks: | Real time quote last updated: 04/12/2025 09:09 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -78,010 |
| %Change | -70.590% |
| EPS / (LPS) | RMB -0.550 |
| NBV Per Share (¥) | RMB -- |